Your Nutrition Partner to improve LifeClinical Nutrition Your nutrition partner to improve life The important role of adequate nutrition during hospital stay is well documented by several different studies. These studies suggest that up to 60% of patients in hospitals are suffering from malnutrition which is often the cause for serious complications such as an increasing risk of sepsis, infection, inflammation or organ failure. The consequences of these complications are reduced wound healing leading to a significantly uprated morbidity and mortality. To avoid these consequences an appropriate nutritional therapy is an indispensable condition especially for critically ill patients. The right nutrition system will not only minimize the risk of morbidity and mortality by strengthening your patients immune system and organ functions, but also lead to a sooner recovery. This will reduce the duration of hospital stay and in the end the costs for treatment. Nowadays clinical nutrition is widely accepted in clinical practice. The lifesaving characteristics of the adequate nutrition can not be denied so it became an important part of the overall treatment package. There are different ways of clinical nutrition: enteral, parenteral or a combination of both. The right way of clinical nutrition always depends on the patients gut function and his general physiological condition. The determination of the nutritional status should be part of each physical examination in order to identify risk patients to evaluate their risk and to define an individual nutrition therapy. The NuTRIscreen-App includes different screening tools, such as "NRS-2002" (Nutrition Risk Score), the "MUST" (Malnutrition Universal Screening Tool) and the "SGA" (Subjective Global Assessment). The NuTRIscreen-App is available at the App Store. The NuTRIscreen-App: References: 1. Wilson et al. Prevalence and causes of undernutrition in medical outpatients. Am J Med 1998; 104; 56-63 2. Norman et al. Clin Nutr (2008) 27; 5-15 3. Stratton et al. (2003) Wallingford: CAB International 4. Neumayer et al. J Surg Res (2001) 95; 73-77 5. Lawson (2002) Clin Nutr (2003) 22(1); 39-46 2 Clinical Nutrition Enteral nutrition support is needed if the patient is unable, unwilling or not allowed to take adequate nutrition from normal food. Use of the gastrointestinal tract for nutrition support allows a physiological utilization of nutrients. Parenteral nutrition on the other hand bypasses the gastrointestinal tract and is given intravenously, either via peripheral or central venous line. Our ready-to-use systems offer standardized nutrition regimes, required by most of enterally or parenterally fed patients. Patient-tailored prescriptions are only necessary in specific clinical situations. Therefore the wide product range and the possibility of making additions allows a highly flexible adaptation to specific patient needs. 16 14 12 10 days Consequences of malnutrition2,3: n Increased hospital stay Increased morbidity and mortality Increase in infectious complications Reduced wound healing n n n 40 30 8 6 4 2 0 no adequate nutrition early and sufficient nutrition 20 % 10 0 control nutrition supplement 10–60 % malnutrition based on 5.120 patients1 Average length of hospital stay in surgical patients in relation to nutritional support 4 Complication rate in orthopedic patients 5 3 Parenteral and enteral ... Nutritional care is a concept which includes several aspects and these must be managed in a seamless way to ensure that the right patients receive the right nutritional support at the right time and in the right place. It is fundamental that nutritional care is based on each patient's individual nutritional requirements and preferences. Any patient who is undernourished or at risk for undernutrition should have a nutritional care plan. The integrated concept of nutritional support offered by B. Braun – enteral and parenteral nutrition going hand in hand – creates a solid platform for different kinds of nutritional treatments, allowing health care specialists to choose from a wide product range, to meet the fundamental requirements of the body. Parenteral Nutrition The parenteral nutrition therapy can be realized with premixed “convenience” solutions or by patient-tailored nutrition. The standardized parenteral nutrition (NuTRIflex® System) is suitable for most of the parenterally fed patients, and has significant advantages by preventing therapeutical errors and reducing work load and total costs for the preparation of nutritional regimens.6 For specific clinical situations (e.g. patients with severe metabolic derangements or organ dysfunctions) and for neonatology, a patient-tailored nutrition therapy based on different single nutritional solutions is required. 6. Pichard et al. Clin. Nutr. (2000) 19(4); 245-251 4 Enteral nutrition allows a physiological utilisation of nutrients and is believed to promote gut function and prevent translocation of intestinal bacteria.Clinical Nutrition . whatever routes of application you are looking for. Braun offers a wide range of enteral nutrition products that cover different indications and routes of application. vitamins and minerals that can be used as a sole source of nutrition or as a supplement.. B. it is all about nutrition Enteral Nutrition B. There are different ways to get access to the gastrointestinal tract. The composition can be a standard formula. carbohydrates. reflecting the nutrition needs of a healthy patient.. Braun formulas are a safe and effective source of nutrition reflecting the requirements of patients and health care professionals alike. However. B. fats. The formulas of enteral nutrition products are a ready to administer mixture of important nutrients like proteins. Braun offers a broad range of pump or gravity application sets as well as naso-gastric or naso-intestinal tubes. or adapted to a specific disease and / or digestive disorder (disease specific formula). 5 . choosing the right feeding method and formula to achieve quality nutritional care is a daily challenge of health care practitioners and dietitians around the world. we also offer resealable nutrition bags which have a fixed. Infusomat® Space – also ideal for clinical nutrition With this system. Braun offers standard and special diets for enteral nutrition in glass bottles and bags. Not only does this save staff time. Braun standardized nutrition solutions are suitable for most enteral and parenteral feeding of patients. because additional user trainings are no more required. Clinical nutrition Modern nutrition therapy involves premixed “convenience” solutions or nutrition solutions specially made for the patient. This approach offers significant benefits as it prevents errors in administering the right therapy during the routine of daily clinical practice.or 3-chamber bags End messy dripping of sticky fluids with PrimeStop No additional training required Enteral Nutrition Parenteral Nutrition Insulin Pump n n n n Space Control User Interface 6 . attached tube for the Infusomat® Space. it also cuts the cost of maintenance and service. Your benefits: n Protect your budgets by using Infusomat® Space also for enteral nutrition Prevent mix-up of enteral lines and IV access ports Reduce nurse’s workloads and the total cost of preparation with ready-to-use 2. For the delivery of enteral nutrition solutions. B. beds equipped with the Space system do not need additional nutrition pumps.Binding forward-looking technology … Successful therapy requires adequate clinical nutrition – which is why we consider parenteral and enteral nutrition as an integral part of modern fluid management systems. Standardization also reduces nurse’s workloads and the total cost of preparation. Enteral nutrition B. and hypoglycemia. Blood sampling and analysis Automatic insulin application 2. Confirmation of suggested insulin rate Automatic calculation of appropriate insulin rate and next sampling time Get in touch with the future B. Glucose (mmol/l) B. Braun Space GlucoseControl integrates enteral and parenteral nutrition and exactly determines insulin rate and next sampling time – helping you to easily control complex work processes for a safer future with minimized episodes of potentially dangerous hyperglycemia and hypoglycemia.1 mmol/l (80–110 mg/dl) 7 . Braun Space GlucoseControl n 20 Conventional Glucose Control The solution to achieve safe and reproducible blood glucose control Automatic Integration of Nutrition More safety in daily clinical workflow Optimized workflow and simplified treatment decision for more safety in daily use n 15 n n 10 5 Time (hours) Strict Glucose Control within a range of 4.4–6. the B. Input of glucose value into SpaceControl 3. Braun Space GlucoseControl: B.Clinical Nutrition … with highest treatment quality Automatic consideration of nutrition data 1. Braun Space GlucoseControl realizes safe and reliable glucose levels in critically ill patients with a significantly reduced risk of hyper. With its intelligent dosage algorithm. 2-chamber bags Provide different formulations with amino acids. Tracutil®) and other micronutrients can be added via the additive port.The NuTRIflex® system for your convenience Convenience with Safety The NuTRIflex® System is the “ready-to-infuse” multi chamber bag system for Total Parenteral Nutrition (TPN). including volume restricted and electrolyte-free versions. Nutriflex® 2-chamber bag NuTRIflex® Lipid 3-chamber bag Amino Acid Lipid Glucose Glucose Amino Acid Latex-free PVC-free Port system n Low risk for needle stick injury n Easy to grip and firm fitting n No leakage after removal n Stable ports made of hard plastic n Self-sealing Latex-free PVC-free DEHP-free 8 . The NuTRIflex® System consists of 2.g. NuTRIflex® Lipid including a MCT/LCT lipid emulsion. According to individual patient requirements. can be added via the lipid additive port.and 3-chamber bags for peripheral and central venous application. 3-chamber bags The 3-chamber bags provide different formulations and bag volumes with amino acids. Lipidem®/Lipoplus®). On individual needs trace elements (e. carbohydrates and fat and are available with or without electrolytes.g. carbohydrates and electrolytes. lipids (e. cost-effective and safe n n 9 . 2.8 -1. through visual check Environmental and patient-friendly bag material (no PVC. Then electrolytes. trace elements and vitamins can be added via the additive port (red cap).2 mm can be used. Remove the overwrap and mix the upper left chamber (Glucose) with the lower chamber (Amino Acid). no DEHP and no latex) Convenient. 1. Finally. Press the upper right chamber (lipid emulsion) to mix with the lower chamber.Parenteral Nutrition Mix – add – mix – infuse The steps: Safety aspect After adding the additives to the clear solution. User benefits n Increase patient safety. 4. 3. mix thoroughly before inserting the giving set. Needles with the size of 0. a visual check is possible. 14 g N ≈ 100 g amino acids. carbohydrates and electrolytes in a 2-chamber bag.8 150 + 790 600 1000.g. 2000 Nutriflex® basal 32 4. Lipofundin®) Characteristics n Different balanced regimens for peripheral and central venous application n Reliable source of protein and calories n Supplies electrolytes n Easy and safe handling n Flexibility to add fat easily to complete parenteral nutrition from one bag n 24-month shelf life at room temperature Accessories Nutriflex® Transfer Set (Art. Lipoplus®. 2000 Nutriflex® plus 48 6. Trade name in some countries: Medialipide®. 2000 Nutriflex® special 70 10. ** may differ from country to country 10 . 212 9043) n Light Protection Cover: Nutriflex® 1000 ml (Art. Trade name in some countries: Lipidem® Composition 1000 ml Amino acids Nitrogen* Glucose Electrolytes Total energy Non-Protein energy Presentations** kcal kcal ml g g g Nutriflex® peri 40 5.2-chamber bags Nutriflex® Sterile solution for intravenous nutrition containing amino acids.6 125 + 630 500 1000. Nutriflex® n PN regimens for individual fat requirements n Flexibility in adding optional lipid emulsions such as Lipoplus®2 or Lipofundin® MCT/LCT1 Product range Nutriflex® peri n Peripheral parenteral nutrition n Supplemented nutrition or in combination with enteral feeding n For Low Glucose Nutrition (LGN) Therapy Nutriflex® basal n Parenteral nutrition in situations with basal nutrition requirements n For central venous access Nutriflex® plus n Parenteral nutrition in situations with moderately increased requirements n For central venous access Nutriflex® special n Volume-restricted parenteral nutrition for ICU patients n situations with high nutritional requirements In All Nutriflex® . 1500 * due to the specific amino acid pattern.0 240 + 1240 960 1000. No.2-chamber bags n Flexibility to choose and add the fat component (e.7 80 + 480 320 1000. No. 212 9035) Nutriflex® 1500 ml. 211 2112) n 1. Vasolipid® 2. No. 2000 ml (Art. 0 35.2 13.4 25.5 25.8 1000 70 10 240 1240 2100 40.2 7.8 38.2 11.0 8.2 50 7.9 plus 2000 96. See manufacturer´s recommendation.8 150 790 1400 37. Vitamins and trace elements should be added just prior to use! There may be some degradation during shelf life.7 20.1 74.6 125 630 1150 49.7 12.1 6.0 71 45.4 63.7 4.5 22.5 1000 40 5.0 11. lipids) its osmolarity.7 80 480 900 peri 2000 80 11.0 14.2 250 1255 1150 99.g.9 30 3.3 33 PLEASE NOTE: Additions to Nutriflex® may increase (e. *Not all versions and bag volumes will be marketed in each country.7 31.6 100 70 1000 48.8 60 7.4 160 960 900 54 30 5.8 50 35 basal 2000 64 9.5 4. electrolyte concentrates) or decrease (e.6 300 1580 1400 74.2 11.6 5.6 19.2 39 1000 32 4.1 5. 11 .g.5 22 special 1500 105 15 360 1860 2100 60.0 5.7 49.4 40.Parenteral Nutrition Clinical Nutriflex® – global portfolio overview* Nutriflex® 2-chamber bag Volume (ml) Amino acids (g) Nitrogen (g) Glucose (g) Total energy (kcal) Osmolarity (mOsm/l) Content Electrolytes (mmol) Sodium Potassium Calcium Magnesium Phosphate Chloride Acetate 27 15 2.6 5.2 25 3.6 6.5 22. 1250. Vasolipid® Characteristics n Allows the simultaneous administration of required nutrients out of one container n Contains MCT/LCT1 lipid emulsion n Electrolyte-containing versions cover the basic needs for electrolytes and zinc n Electrolyte-free versions for individualized electrolyte administration n Easy and safe handling n 24-month shelf life at room temperature Accessories Light Protection Cover: NuTRIflex® Lipid 1250 ml. 211 2112) NuTRIflex® Lipid 625 ml (Art. 14 g N ≈ 100 g amino acids. 212 9035) n Composition 1250 ml Amino acids Nitrogen* Glucose Lipids (MCT/LCT) Electrolytes Total energy Non-Protein calories Presentations** kcal kcal ml g g g g NuTRIflex® Lipid peri 40 5. 2500 48 6. 2500 ml (Art. 2500 71. 2500 NuTRIflex® Lipid special without electrolytes NuTRIflex® Lipid special 71. 2500 NuTRIflex® Lipid plus without electrolytes NuTRIflex® Lipid plus 48 6. 1875 ml.8 10 180 50 + 1475 1195 625. 1875. No. 2500 * due to the specific amino acid pattern. vitamins and trace elements The only 3-chamber bag with MCT/LCT1 lipid emulsion Reduces work load and total cost for TPN NuTRIflex® Lipid special 625 ml . No. Trade name in some countries: Medialipide®.7 80 50 + 955 795 1250.8 150 50 + 1265 1075 1250.8 10 180 50 1475 1195 1250. 1875.3-chamber bags NuTRIflex® Lipid Sterile solution for IV nutrition containing amino acids. 1875.as ”ICU starter bag” – for combined enteral/parenteral nutrition – as basic ”all-in-one” bag for children (>2 years) n n n n n Product range NuTRIflex® Lipid peri n Peripheral parenteral nutrition n Supplementary nutrition n combination with enteral nutrition In n Specially designed for Low Glucose Nutrition (LGN) Therapy (peripheral and central venous) NuTRIflex® Lipid plus n Central venous parenteral nutrition for moderately increased requirements n Easy to calculate: 1 ml = 1 kcal NuTRIflex® Lipid special n volume-restricted parenteral nutrition is required If n situations with high nutritional demands In n 625 ml version as ICU starter bag and for combined enteral/parenteral nutrition NuTRIflex® Lipid without electrolytes (plus and special) n For individualized electrolyte administration 1. NuTRIflex® Lipid n Easy and safe parenteral nutrition Metabolic advantages through simultaneous administration of nutrients Compatibility and stability data offer safe limits for the addition of further required minerals. 1875. 1875. carbohydrates and lipids in a 3-chamber bag – available with and without electrolytes.8 150 50 1265 1075 1250. ** may differ from country to country 12 . 04 a) 1875 72 10. See manufacturer’s recommendation.06 2500 143. *Not all versions and bag volumes will be marketed in each country.5 4.0 60 60 0.045 2500 80 11.8 10 180 50 1475 1545 67 47 5.06 1250 48 6.95 7.3 20.0 6.6 300 100 2530 1215 100 70 8.6 40.5 0.3 5.65 10. 13 .5 2.03 1250 40 5.8 150 50 1265 1215 50 35 4.65 2.5 48 40 0.03 plus a) special 2500 96 13.02 1250 71.0 7.045 1875 107.5 7.6 10.06 625 35.0 45 45 0.0 15.0 30 30 0.7 80 50 955 840 peri 1875 60 8.5 23.Parenteral Nutrition NuTRIflex® Lipid – global portfolio overview* 2500 ml NuTRIflex® Lipid Special in a 625 ml bag 1875 ml This unique size is especially suited for: n Patients requiring an incremental increase in TPN during their first days on ICU n Combining enteral and parenteral nutrition n Children (> 2 years) as a basic “all-in-one” bag for convenient TPN 1250 ml 625 ml NuTRIflex® Lipid 3-chamber bag Volume (ml) Amino acids (g) Nitrogen (g) Glucose (g) Lipids (g) Total energy (kcal) Osmolarity (mOsm/l) Content Electrolytes (mmol) Sodium Potassium Calcium Magnesium Phosphate Chloride Acetate Zinc 50 30 3.5 70.4 160 100 1910 840 100 60 6.2 225 75 1900 1215 75 52.0 22.08 PLEASE NOTE: Additions to NuTRIflex® Lipid may increase its osmolarity.0 8.95 30. a) NuTRIflex® Lipid plus and special also exist as electrolyte-free versions (e-fr.0 3.0 90 90 0.0 4.0 6. Vitamins and trace elements should be added just prior to use! There may be some degradation during shelf life.9 5 90 25 740 1545 33.25 72 60 0.6 20 360 100 2950 1545 134 94 10.5 11.0 15.5 6.5 67.6 120 75 1435 840 75 45 4.0 30.0 96 80 0.7 15 270 75 2215 1545 100.0 90 90 0.0 120 120 0.5 67. plus/special: 1055/1330 mOsm/l). This procedure is time-consuming and requires extensive technical equipment and pharmaceutical know-how. liver or renal insufficient patients) sometimes require patient-tailored TPN because their nutrient requirements are specific and tend to vary significantly from patient to patient and during each patient's hospital stay. Against this background. malnourished patients with compromised metabolic and organ functions (e. significantly catabolic.g. 14 . Traditionally. this kind of nutrition therapy is prepared at the hospital pharmacy by compounding the different required components into one mixing bag. the NuTRIflex® System allows hospital compounding services to focus on those 10%–20% critically ill patients requiring patient-tailored nutrition support.The single bottle system … Patient-tailored regimens Critically ill. Trade name in some countries: Medialipide®. Braun: Amino acid solutions for parenteral nutrition n Aminoplasmal® Hepa: Amino acid solution for parenteral nutrition in severe liver disease and for the therapy of hepatic encephalopathy Lipoplus®/Lipidem®: Modern fat emulsion based on medium and long chain triglycerides including -3 fatty acids n Lipofundin® MCT/LCT 1: Fat emulsion on the basis of medium and long chain triglycerides n Glucose Braun: Glucose solution for providing energy n Tracutil®: Trace element additive n Nutrimix®: EVA mixing bags n User benefits n Wide range of product versions for patient-tailored TPN Excellent stability in TPN admixtures Well balanced MCT/LCT lipid emulsion with -3 fatty acids n n 1.Parenteral Nutrition … for parenteral nutrition Compounding of a Nutrimix® mixing bag Product range n Aminoplasmal® B. Vasolipid® 15 . Driscoll DF. Braun 5% E g g kcal ml 50 8 + 200 250. Braun Amino acid solution for parenteral nutrition. Aminoplasmal® B. 1000 + Aminoplasmal® Hepa 10 % 100 15. 1000 Aminoplasmal® B. Supplement 1. Braun 10% 10 % E 100 100 16 400 250. Amini acid metabolism during parenteral nutrition in healthy volunteers: evaluation of a new amino acid solution.3 400 500 16 . Trade name in some countries: Medialipide®. Aug 2002 Allows to provide adequate protein supply to patients suffering from liver insufficiency Characteristics n 5%. Berard MP. Clin Nutr 2001 20(5) 407-414 2. Cynober L. 500. Trade name in some countries: Lipidem® 4. Physicochemical stability of highly concentrated all-in-one mixtures intended for fluid restricted patients. Vasolipid® Composition 1000 ml Amino acids Nitrogen Electrolytes Energy Presentations* * may differ from country to country Aminoplasmal® B. 1000 + Aminoplasmal® 15 % 15 % E 150 150 24 600 500. 10% and 15% amino acid concentrations n Balanced content of essential and non-essential amino acids n Amino acid pattern for patients > 2 years of age n Available also as electrolyte free versions n Very good stability in all-in-one mixtures n ompatible with Lipoplus®3 and Lipofundin® MCT/LCT4 C containing all-in-one mixtures n lectrolyte free versions do not contain chloride E Characteristics n Specific amino acid pattern adapted to the specific needs of patients with liver insufficiency n High concentration of branched chain amino acids n Reduced aromatic amino acid and methionine content 3. Aminoplasmal® Hepa 10% Amino acid solution for parenteral nutrition for patients with severe liver diseases and for treatment of hepatic encephalopathy. Clin Nutr Vol 21. Braun n Aminoplasmal® Hepa n Maintenance of equilibrium of amino acids in blood1 Excellent stability in TPN mixtures2 Normalization of cirrhosis-induced amino acid imbalances Improved clinical situation in hepatic encephalopathy n n n 1. Hankard R.Amino acids Aminoplasmal® B. 500. Barbosa VM et al.14(1):R5. Vasolipid® Characteristics n Contains MCT (coconut).improves oxygenation index4 n n n 2.reduced length of hospital stay3. 250. LCT (soybean) and -3 triglycerides (fish oil) n For peripheral and central venous application n Excellent stability in all-in-one admixtures n Supplemented with vitamin E n The combination with Nutriflex® 2-chamber bag allows quick.Parenteral Nutrition Lipid emulsions Lipofundin® MCT/LCT 1 Fat emulsion for parenteral nutrition on the basis of medium and long chain triglycerides. Wichmann et al. 500 Lipoplus® 20 % or Lipidem® 20% 80 100 20 12 25 1910 190 ± 30 100. lung and immune function Improves protein economy Superior stability improves safety One lipid emulsion for all patients Antioxidative protection to prevent peroxidative damages n Inflammation-modulating effects . Lipoplus® 2 has a well-balanced 3 : 6 ratio of 1: 2. 250. 500 Composition 1000 ml Soybean oil (LCT) MCT oil (coconut) Omega-3 acid triglycerides Egg yolk lecithin Glycerol Total energy α-Tocopherol (Vitamin E) g g g g g kcal mg ml Presentations* * may differ from country to country 17 . Lipoplus® 2 or Lipidem® New generation of lipid emulsion.7. 2010. 4 . Crit Care Med 2007. 250. Trade name in some countries: Medialipide®. Epub 2010 Jan 19 Characteristics n Registered for use in neonates and children n For peripheral and central venous application n Excellent stability in TPN admixtures n Supplemented with Vitamin E 1. achieved by adding highly purified fish oil -3 fatty acid triglycerides. 700-706 4. Lipofundin® MCT/LCT1 n Lipoplus®2 n Protects liver. Trade name in some countries: Lipidem® 3. 500 Lipofundin® MCT/LCT 1 20 % 100 100 – 12 25 1908 170 ± 40 100. MCT as preferential fuel for the body with physicochemical and metabolic advantages. In addition to the well known characteristics of Lipofundin® MCT/LCT 1. easy and stable preparation of all-in-one regimens Lipofundin® MCT/LCT 1 10 % 50 50 – 8 25 1022 85 ± 20 100. Administration of LCT as source of essential (polyunsaturated) fatty acids for structural components of cell membranes and as precursors of eicosanoids. 35. Crit Care. glass bottle 500 ml/1000 ml 18 .55 0. Molybdenum. Fluoride and Iodide n Meets the daily requirements of essential trace elements Composition® 1000 ml Glucose Energy Presentations* * may differ from country to country Glucose g kcal 10% 100 400 20% 200 800 30% 300 1200 40% 400 1600 50% 500 2000 70 % 700 2800 Composition® Tracutil Iron Zinc Manganese Copper Chromium Molybdenum Selenium Fluoride Iodide Presentation* * may differ from country to country mg/10 ml 2 3. Used as a supplement in parenteral nutrition.Glucose solutions and trace elements Glucose Braun Glucose solutions for providing energy (and fluid) in parenteral nutrition. Manganese.76 0.01 0.2 0. Zinc.01 0.13 5 x 10 Ampoule µmol/10 ml 35 50 10 12 0. Copper. Selenium.57 0.1 0. Chromium.3 0. Tracutil® Trace element additive for adults. Glucose Braun n Tracutil® n Essential energy source for organs and tissues Supply of trace elements in parenteral nutrition of adults Compatible with a wide range of nutritional admixtures n Characteristics n Basic component in parenteral nutrition n Delivers approximately 4 kcal/g glucose n Wide range of concentrations available Characteristics n Balanced mixture of the 9 trace elements Iron.3 30 1 Ecoflac® plus 500 ml.02 0. 2/0 Nutrimix® Dual Chamber Bags (2500 + 500 ml) Nutrimix® Dual Chamber Bags (1250 + 250 ml) Transfer Set * may differ from country to country Volume 200 ml 500 ml 1000 ml 2000 ml 3000 ml 3000 ml 2000 ml 1000 ml 500 ml 200 ml 3000 ml 1500 ml 0 Filling lines 0 0 0 3 3 0 0 0 0 0 0 0 4 Units/Packages 1 1 1 1 1 5 5 5 5 5 1 1 1 Packages/Carton 25 25 25 25 25 25 25 40 50 50 25 25 25 19 .2/0 Nutrimix® 0.Parenteral Nutrition Mixing bag Nutrimix® Traditional EVA mixing bag for easy and safe handling.g. Nutrimix® Barrier Mixing Bag made of Multi-Layer Film to protect individual TPN preparations from oxidation. Nutrimix® DC Dual chamber bag for stable separate storage of individual TPN preparation. (REF) 2112145 2112146 2112147 2112150 2112151 2112444 2112443 2112442 2112441 2112440 2112446 2112445 2112449 Presentations* Nutrimix® 0.g.5/0 Nutrimix® Barrier 0.5/0 Nutrimix® 1/0 Nutrimix® 2/3 Nutrimix® 3/3 Nutrimix® Barrier 3/0 Nutrimix® Barrier 2/0 Nutrimix® Barrier 1/0 Nutrimix® Barrier 0. of amino acid-glucose mixture separate from lipid emulsion and therefore longer storage of compounded lipid-containing TPN formulations High flow filling port n n n n n n n n n Easy and safe handling n Sterile outlet port with snap-off cap to ensure easy and safe handling Code No. specially suitable for fat-containing TPN regimens Prolongs the stability of oxygensensitive compounds (e. specially suitable for fat-containing TPN regimens Dual chamber allows preparation with separate storage e. vitamins) Ensures longer shelf life of compounded regimens Sterile outlet port with snap-off cap ensures easy and safe handling 100%-Latex free and DEHP-free. Nutrimix® n Nutrimix® Barrier n Nutrimix® DC n 100% Latex-free and DEHP-free. specially suitable for fat-containing TPN regimens Additive injection port with closure cap Detachable transfer set with lock connector Sterile outlet port with snap-off cap 100% Latex-free and DEHP-free. Enteral Nutrition – well-being and quality … 20 . and micronutrients adapted to the patients needs. fibre contraindicated or inadvisable fibre contraindicated or inadvisable rich in fibre high energy and protein needs. depending on patient’s needs n -3 fatty acids from fish oil n Fibre containing versions (most variations with prebiotic fibre) Variations high in energy and protein for patients with (combined protein-) energy malnutrition Diabetes product containing carbohydrates from starch. chronic inflammatory diseases severe disorders of digestion and assimilation. rich in monounsaturated fatty acids.Enteral Nutrition … through complete and balanced nutrition Nutricomp® liquids Liquid enteral nutrition diets like Nutricomp® from B.and micronutrients (nutritionally complete dietary food) n Fat from different sources. stress. pancreas failure Nutricomp® Nutricomp® Nutricomp® Nutricomp® Standard Energy Drink Plus Standard Fibre Nutricomp® Energy Fibre Nutricomp® MCT Nutricomp® Nutricomp® Standard Hepa Fibre D Nutricomp® Intensiv Nutricomp® Immun Nutricomp® Peptid Nutricomp® MCT 21 . respiratory failure impaired immune function. plastic or glass bottles that can be applied as oral nutritional supplements or as tube feeding. Braun contain macro. cancer. rich in fibre fat malabsorption. Nutricomp fomulae come in different formats such as bags. fibre contraindicated or inadvisable high energy and protein needs. steatorrhea diabetes mellitus hepatic disease posttraumatic metabolic condition. HIV-infection. Characteristics n Different formulae for individual needs of patients (standard and special diets) n Allows the adequate application of all macro. fortified with antioxidants Versions containing MCT oil for patients with impaired lipid digestion Further products adapted to special metabolic conditions n n n n Sip feed normal digestion and absorption Tube feedTube feed normal digestion and absorption malabsorption and maldigestion normal metabolic condition pathological metabolism high energy needs. rapeseed oil and fish oil n Ratio of 3: 6: 9 fatty acids: Energy: 1: 1.1 Standard Fibre: 1: 3.0% special prebiotic composition). (neutral) caramel. Nutricomp® Energy Nutricomp® Energy Fibre Special diet high in energy and protein without or with fibre (2.5 kcal High quality protein: 75% milk protein 25% soy protein n Characteristics Caloric density: 1 ml = 1. mixed) 1. strawberry.0 n as a combination of Fat soy oil.5 kcal High quality protein: milk protein (70.5 n as a combination of Fat MCT (50%).2: 2.6 Energy Fibre: 1: 1.3: 3. rapeseed oil (only Standard Fibre) MCT and fish oil n Ratio of 3: 6: 9 fatty acids: Standard: 1: 5. Characteristics Caloric density: 1 ml = 1.5% fibre (special prebiotic composition). MCT and fish oil n Ratio of 3: 6: 9 fatty acids: 1: 3.6: 2.5 n Sip feed Composition 1000 ml Total energy Protein Fat Carbohydrates Fibre Nutricomp® Drink Plus 1500 60 50 200 0 16: 30: 54: 0 Nutricomp® Standard 1000 38 33 138 0 15: 30: 55: 0 500 ml bag (neutral) 200 ml plastic bottle (vanilla. May differ from country to country Tube feed Nutricomp® Standard Fibre 1040 38 33 138 15 15: 29: 53: 3 500 ml bag (neutral) Nutricomp® Energy 1500 75 50 188 0 20: 30: 50: 0 500 ml bag (neutral) 500 ml glass bottle (neutral) Nutricomp® Energy Fibre 1560 75 50 188 20 20: 29: 48: 3 500 ml bag (neutral) 500 ml glass bottle (neutral) kcal g g g g Caloric distribution % kcal (Protein : Fat : Carbohydrate : Fibre) Presentations1 500 ml glass bottle 500 ml glass bottle (neutral. strawberry) 22 . Nutricomp® Standard Nutricomp® Standard Fibre Standard diet without or with 1. banana. vanilla.8%) soy protein (29%) n Characteristics Caloric density: 1 ml = 1 kcal High quality protein: 60% milk protein 40% soy protein n n n n as a combination of Fat rapeseed oil.Enteral Nutrition – nutritionally complete … Nutricomp® Drink Plus Standard diet high in energy without fibre. chocolate.3: 5. sunflower oil.2: 2. Fat fish oil and rapeseed oil n Ratio of 3: 6: 9 fatty acids: 1: 2.0% fibre (high amount of soluble fibre).7 n from MCT (50 %) and Fat soy oil (43%) n Ratio of 3: 6: 9 fatty acids: 1: 7: 3 n With antioxidants Tube feed Nutricomp® Standard Fibre D 1030 41 35 129 15 16: 31: 49: 4 Nutricomp® MCT 1300 56 44 171 0 17: 30: 53: 0 Nutricomp® Hepa 1300 40 58 155 5.1 n Rich in MUFA (60% of fat energy) n n from MCT (60%) and Fat soy oil (40 %) n Ratio of 3: 6: 9 fatty acids: 1: 7: 2.0 kcal High quality protein: 75% milk protein 25% soy protein Nutricomp® MCT Special diet adapted to nutritional needs of patients with impaired lipid digestion.3 kcal High quality protein: 60% milk protein 40% soy protein n Characteristics Caloric density: 1 ml = 1. Nutricomp® Hepa Special diet adapted to nutritional needs of patients with impaired liver function with low amount of fibre.1: 9. n n Characteristics Caloric density: 1 ml = 1. Characteristics Caloric density: 1 ml = 1.6 12: 40: 48: 0 Composition 1000 ml Total energy Protein Fat Carbohydrates Fibre kcal g g g g % kcal Caloric distribution (Protein : Fat : Carbohydrate : Fibre) Presentations1 500 ml bag (neutral) 500 ml bag (neutral) 500 ml bag (chocolate) 500 ml glass bottle (neutral) 500 ml glass bottle (neutral) 500 ml glass bottle (chocolate) 23 .Enteral Nutrition … food for special medical purposes Nutricomp® Standard Fibre D Special diet adapted to nutritional needs of patients with diabetes mellitus with starch and 2.3 kcal Specific amino acid pattern: milk protein branched-chain amino acids n n n from sunflower oil. 4 n n as a combination of Fat MCT (44 %) and soy oil (47 %).995 kcal (1500 ml) Fortified with antioxidants n Tube feed Composition 1000 ml Total energy Protein Fat Carbohydrates Fibre Nutricomp® Intensiv 1300 65 58 130 0 20: 40: 40 : 0 Nutricomp® Immun 1360 66. Characteristics n Caloric density: 1 ml = 1.2 188 0 14: 12: 74: 0 500 ml bag 500 ml glass bottle (neutral) 1.33 kcal n Characteristics Caloric density: 1 ml = 1 kcal High quality protein: 61% milk protein 39% soy protein High quality protein: 61% milk protein 38% wheat protein hydrolysate n Special amino acid pattern n High quality protein: 45% milk protein 55% soy protein and gelatine n Protein as defined oligopeptides: free amino acids oligopeptides n from MCT (51%) and Fat soy oil (47 %) n Ratio of 3: 6: 9 fatty acids: 1: 7: 2.8 37 183. respiratory failure. Nutricomp® Peptid Special diet adapted to nutritional needs of patients with maldigestion and malabsorption.4 20: 24: 54: 2 Nutricomp® Peptid 1000 38 11. Nutricomp® Immun Special diet adapted to nutritional needs of patients with impaired immune functions with fibre.Food for special medical purposes Nutricomp® Intensiv Special diet adapted to nutritional needs of patients with posttraumatic metabolism. fish oil n Ratio of 3: 6: 9 fatty acids: 1: 2. sunflower oil. May differ from country to country kcal g g g g Caloric distribution % kcal (Protein : Fat : Carbohydrate : Fibre) Presentations1 500 ml glass bottle (neutral) 500 ml glass bottle 24 .7 n as a combination of Fat MCT (42 %) rapeseed oil.3 kcal n n Characteristics Caloric density: 1 ml = 1. milk fat n Ratio of 3: 6: 9 fatty acids: 1: 6.9: 4.2 n Rich in glutamine: 30 g per 1.4 13.9: 3. 8721726 8721734 8721742 8721688 8721750 8721744 25 . 8710350 8721670 8721061 Presentations* Enteroport® plus Set 500 Enteroport® plus Set 1000 Enteroport® plus Set 2500 Enteroport® plus Set FL Enteroport® plus Set Multispike Enteroport® plus Set Universal Adapter * may differ from country to country Art. 1000. For inpatient and outpatient use.Enteral Nutrition Enteral Nutrition application sets: Enteroport® plus and accessories Enteroport® plus Enteral nutrition pump for controlled gastric and intestinal application of tube feeding diets. No. bolus volume: 1-1000 ml n Integrated safety functions with acoustic and visual alarms n Memory function n Rechargeable batteries. Pump administration sets Enteroport® plus Set with storage bag (500. 2500 ml) Enteroport® plus Set FL with connector for crown cork bottles Enteroport® plus Set Multispike for use with bags Enteroport® plus Set Universal Adapter for crown cork and wide neck bottles and bags Characteristics n Easy to operate and for mobile use n Small size. No. bolus application n Infusion rate: 1-400 ml/h. low weight (450 g) n Operating modes: continuous application. mains input Characteristics n DEHP free n Combined cone and female Luer-Lock connector with closure cap n Conformity to DIN EN 1615 n Y-adapter for Luer syringes n Length: 210 cm n Roller clamp and drip chamber Presentations* Enteroport® plus 230 V Supportstand Pole clamp * may differ from country to country Art. volume / time selection. 26 . Not only does this save staff time. it also cuts the cost of maintenance and service. because additional user trainings are no more required.Infusomat® Space System The ICU-Solution for Clinical Nutrition Infusomat® Space – ideal for clinical nutrition Hospitals equipped with a Space system do not require additional pumps dedicated to nutrition. No. User benefits The only enteral line which supports the use of patient tailored EN and safe system compatibility of an "allround pump".Enteral Nutrition Infusomat® Space Line Type Enteral Nutrition with integrated nutrition bag Infusomat® Space Line Type Enteral Nutrition with universal connector Ready-to-Use solutions Adapter for most ready-to-use containers n With mix-up proof patient connector n Scaled cone adapter n PVC-free n Presentations* Infusomat® Space Line Type Enteral Nutrition. 8250857SP Patient Tailored Solution n With integrated 1000 ml nutrition bag n With mix-up proof patient connector n Scaled cone adapter n Needle-free Y-Port with integrated BCV n DEHP-Free Presentations* Infusomat® Space Line Type Enteral Nutrition. with universal connector Art. No. 27 . For wide neck (screw cap) of plastic bottles. * may differ from country to country User benefits The only multifunctional enteral line which supports safe system compatibility of an "allround pump". with 1000 ml nutrition bag Art. 8250839SP For crown cap of glass bottles. g. No. Enteroport® plus Set Multispike. 2500 ml) Nutrifix® FL with connector for crown cork bottles Nutrifix® Multispike for use with bags Nutrifix® Universal Adapter for crown cork and wide neck bottles and bags Characteristics n DEHP free n Combined cone and female Luer-Lock connector with closure cap n Conformity to DIN EN 1615 Characteristics n Storage bag (1000 ml) n Connection with Multispike connector (e. No. Enterofix® 1000 Bag for fluid application to be used with Multispike connector. 9240677 9240685 9240669 9240632 9240621 Presentations* Enterofix® 1000 Art. Nutrifix® Multispike) Presentations* Nutrifix® 1000 Nutrifix® 2500 Nutrifix® FL Nutrifix® Multispike Nutrifix® Universal Adapter * may differ from country to country Art.Enteral Nutrition application sets Nutrifix® Gravity administration sets. Nutrifix® Set with storage bag (1000. 9240799 28 . 5 CH4. TR = funnel connector. No. 4371143 4371160 4371186 4396049 4396057 4396154 4396251 4396308 4396359 4396405 4372166 * may differ from country to country LL = Luer-Lock.5 CH6 CH9 CH9 CH12 CH12 CH16 122 cm 122 cm 122 cm 38 cm 50 cm 50 cm 50 cm 100 cm 50 cm 100 cm 80 cm Art. TR/M = funnel connector/Mandrin (stylet) 29 . flexible. LL/M = Luer-Lock/Mandrin (stylet).Enteral Nutrition Nasal tubes Nutritub® Polyurethane feeding tubes for long-term naso-gastric and naso-intestinal tube feeding. TR/M = funnel connector/Mandrin (stylet) L = Luer. No. Characteristics n Made of soft polyurethane. without softeners n Radiopaque stripes. Gastric and duodenal tubes Naso-gastric and nasointestinal PVC tubes for short term use. male Luer-Lock connector n Some tubes are equipped with a stylet n Intestinal tubes have weighted ends Presentations* Nutritub® Paed Nutritub® Gastral Nutritub® Gastral Nutritub® Gastral Nutritub® Gastral Nutritub® Gastral Nutritub® Intestinal Nutritub® Intestinal LL LL LL/M TR/M TR/M TR TR/M TR/M CH 6 CH 8 CH 8 CH 8 CH 12 CH 15 CH 8 CH 12 60 cm 100 cm 100 cm 100 cm 100 cm 100 cm 120 cm 120 cm Art. length markings n Funnel connector with integrated syringe adapter. 9246509 9246517 9246525 9246533 9246541 9246550 9246576 9246584 Characteristics Closed ends n Two or four lateral eyes n Radiopaque stripe n Gastric tube CH 16 equipped with a stylet n Presentations* Duodenal tube Duodenal tube Duodenal tube Gastric tube Gastric tube Gastric tube Gastric tube Gastric tube Gastric tube Gastric tube Gastric tube TR TR TR L L L L L L L TR/M CH14 CH16 CH18 CH4. TR = funnel connector. 95 0. In cases of concurrent renal insufficiency the dos- age of amino acids has to be adapted to the serum urea and creatinine values. Precautions: Clinical supervision should include regular checks of fluid balance and serum electrolytes. Braun Melsungen AG 34209 Melsungen.20 11.70 5.00 8. hyperhydration.40 4. Precautions for use and special warnings: .3 10 %E 100 16 400 1.86 g (equivalent to Tyrosine 0. Braun 5%E 10% 10 %E 2.50 5.50 g 10.50 g 0. carbohydrate solutions.80 g 13.75 1. .70 5.60 2.80 3.60 g 4.40 5.48 g) 8.70 g Ornithine Hydrochloride 1.3 50 25 2. .50 3.Hyperhydration. .80 3. Braun Melsungen AG 34209 Melsungen.78 4.35 7. if admixture with Aminoplasmal® Hepa10 % is essential.50 16.70 g 6.20 22.40 2.60 g 8.42 2.30 g 7.0 35 36 Indications: Supply of substrate for protein synthesis in the setting of parenteral nutrition.20 1.60 6. but should preferably be given in standard carbohydrate or electrolyte solutions.35 7.67 g) Water for Injections to 1000 ml Total amino acids 100 g/l Total nitrogen 15. Germany Excipients Sodium hydroxide.30 0. infants. Side-effects Provided contraindications.3 50 25 2. Parenteral nutrition in liver diseases when hepatic encephalopathy is either imminent or already manifest. e. Carbohydrates and electrolytes are to be supplemented as required. acidosis. disodium edetate.40 2.20 5.50 5. .25 19.Acidosis.Dangerous circulation disorders (shock).30 g 8.00 5.20 3.Hypokalaemia.85 11.Caution is to be exercised in patients with increased serum osmolarity.00 10. .51 g) Methionine Phenylalanine Threonine Tryptophan Valine Arginine Histidine Glycine Alanine Proline Aspartic Acid Asparagine · H2O (equivalent to Asparagine 0.70 5.60 7. serum electrolytes. such as purging.05 5.3 g/l Caloric value: 1675 kJ/l 400 kcal/l Osmolarity: 875 mOsm/l Electrolytes: Acetate 51 mmol/l Chloride 10 mmol/l Indications: Treatment of hepatic encephalopathy.Disorders of amino acid metabolism. B.37 g) Glutamic Acid Serine Tyrosine Aminoplasmal® 15 % 15 %E 5.20 g 1. hyponatraemia. dosage recommendations and precautions are observed.05 5.40 Total amino acids (g) Total Nitrogen (g) Caloric value (kcal) Theoretical osmolarity (mOsmo/L) pH Electrolytes (mmol) Sodium Potassium Magnesium Phosphate Acetate Chloride 5 %E 50 8 200 588 5. blood glucose and acid-base balance. .00 0.7 – 6.50 2. hypokalaemia.Acute renal failure with increased non-protein nitrogen concentrations in the serum. shock).56 3.95 g) Methionine Phenylalanine Threonine Tryptophan Valine Arginine Histidine Glycine Alanine Proline Aspartic Acid Acetylcysteine (equivalent to Cysteine 0.12 2.40 4.021 5. Contraindications Aminoplasmal® – 15% must not be used when there are .50 4. Germany Specific Product Information may differ from country to country 30 .70 5. in the treatment of hepatic encephalopathy.0 5. On account of its amino acid composition.20 22.20 11. B.87 2.00 10.90 5.0 Aminoplasmal® Hepa 10% Composition Each 1000 ml contains: Isoleucine Leucine Lysine Acetate (equivalent to Lysine 7.80 g (equivalent to Cysteine 0.78 4.7 – 6.60 7.25 6.85 11.35 g) Serine 3.35 7.0g 600 600 1290 1480 30 mmol 30 mmol 5.50 3. Braun Composition Each 1000 ml contains: Amino acids: (g) Isoleucine Leucine Lysine acetate (equivalent to Lysine) Lysine monohydrate (equivalent to Lysine) Methionine Phenylalanine Threonine Tryptophan Valine Arginine Histidine Alanine Glycine Aspartic acid Glutamic acid Proline Serine Tyrosine Aminoplasmal® B.03 1. However. Subject to sales by pharmacists only. In parenteral nutrition.60 g 10.Hyponatraemia.00 8.70 g Acetyltyrosine 0.20 2.00 5.40 5.10 0.7 – 6.50 16. water for injections Total amino acids (g) Total nitrogen (g) Caloric value (kcal) Theoretical osmolarity (mOsmol) Titration acidity (to pH 7.35 7.00 0. It is not recommended that any additives be incorporated into Aminoplasmal® Hepa-10 % solution.55 g Acetylcysteine 0.e.07 3. Normalisation of amino acid imbalances arising from severe liver diseases. hypokalaemia.6 9.50 Electrolytes (mmol) Sodium Potassium Magnesium Phosphate Acetate Chloride 15% - 15 %E 50 30 2.80 g 4.4) pH 150g 150g 24.20 16. .10 7.20 3.60 g 1. Amino acid therapy is not a substitute for established therapeutic measures.60 g 1.5 – 7. . Braun 10% should only be administered after careful benefit-risk assessment in the presence of: disorders of amino acid metabolism.00 2.Individual dosage regimens must be established for patients with hepatic and renal insufficiency.0g 24.90 5.25 19.g.74 4.40 8.60 6. Braun Melsungen AG 34209 Melsungen. Contraindication: Severe circulation disorders with vital threat (i.5 – 7.40 8.07 3. This solution should not be given to neonates.66 g (equivalent to Ornithine 1.74 4.30 0. Contraindications: Disturbances of amino acid metabolism of other than hepatic origin.Clinical supervision should include regular checks of fluid balance.50 12.5 10 35 45 10% 100 16 400 864 5. Germany Aminoplasmal®-15% /15%E Composition Each 1000 ml contains: Active ingredients (g) Isoleucine Leucine Lysine Monohydrate (equivalent to Lysine 7.15 0. Caution is to be exercised in patients with hyponatraemia or with increased serum osmolarity.10 7.70 4.20 5. side-effects are not anticipated. administration of lactulose and/or gut sterilising antibiotics.20 1.93 5.45 2. amino acid infusions should always be accompanied by administration of sufficient amounts of caloric solutions.35 2.Advanced liver disease. Cellular oxygen deficiency (hypoxia) or acidosis. . and children up to the completed 2nd year as the nutrient relations do not properly meet the special paediatric requirements.10 5.Product Description Parenteral Nutrition Aminoplasmal® B.50 2. then the compatibility of the additive must be checked before administration.5 10 46 52 Therapeutic indications: Supply of substrate for protein synthesis in parenteral nutrition.95 0. overhydration.93 5.20 16. B.70 4. Special warnings and special precautions for use: Aminoplasmal® B. Unusally rapid infusion rates may produce signs of intolerance and renal amino acid losses resulting in amino acid imbalances. is not to be administered in infants and children up to the completed 2nd year.75 1.59 g) Glutamic Acid 5.50 12.10 g 2.12 2. Patient monitoring should also include regular checks of the water balance. Subject to sale by pharmacists only. or after administration of blood. Nevertheless.5-8. A too rapid infusion of Lipofundin® MCT/LCT can also cause hyperketonaemia and/or metabolic acidosis. As long as approval has not been obtained in a specific country it is up to the judgement of the responsible physician whether or not to use Lipofundin® MCT/LCT in this patient group. B. Indications: Lipofundin® MCT/LCT is indicated as a source of calories and essential fatty acids for patients requiring parenteral nutrition. Contraindications: The administration of Lipofundin® MCT/LCT is contraindicated in patients demonstrating disturbances in normal fat metabolism such as pathologic hyperlipaemia. When Lipofundin® MCT/LCT is administered. Administration of Lipofundin® MCT/LCT should be accompanied by simultaneous carbohydrate infusions making up to 40% (at least) of the total calorie intake.0 g Egg yolk phospholipids* 8. Precautions for use: Caution should be exercised in administering intravenous fat emulsions in patients with metabolic acidosis. in thromboembolism and in acute shock states.5-8. Germany Indications: . unless the expected benefit is thought to outweigh any possible risk to the foetus. Medium-chain triglycerides are a mixture of neutral triglycerides of mainly caprylic (about 60%) and capric acid (about 40%).Hyperhydration . but its use dur- ing these periods is not considered to constitute a hazard. Patient monitoring should include regular checks of the blood glucose level. Braun Melsungen AG 34209 Melsungen. pulmonary disease.0 g 100.Therapy of hypoglycaemia Lipofundin® MCT/LCT 1 Composition 1000 ml emulsion contain Lipofundin® Lipofundin® MCT/LCT 10% MCT/LCT 20% Soybean oil 50. overhydration. before.Simultaneous sodium and water deficiency (hypotonic dehydration) Special warnings and precautions for use This solution should only be administered with caution to patients with increased serum osmolarity. Registration procedures are currently pursued in other countries. severe liver damage. the patient's haemogram. It is further contraindicated in patients with ketoacidosis or hypoxia. Glucose Infusions should not be administered through the same infusion equipment. lipoid nephrosis. depending on the prevailing metabolic condition and the administered dose.0 g Sodium Oleate.Parenteral Nutrition Product Description Parenteral Nutrition Glucose Intravenous Infusion Composition Each 1000 ml solution contains: Glucose 30% 40% 300 400 330 440 300 400 5025/ 6700/ 1200 1600 1665 2220 Glucose As glucose monohydrate Carbohydrate contents Caloric value Theor. α-Tocopherol*.0 g 12.0 g Mediumchain Triglycerides 50.Elevated blood sugar concentration (hyperglycaemia) . Osmolarity (g) (g) (g) (kJ/ kcal) (mOsm/l) 10% 100 110 100 1675/ 400 555 20 % 200 220 200 3350/ 800 1100 50% 500 550 500 8375/ 2000 2770 70 % 700 770 700 11725/ 2800 3880 Contraindications: . anaemia or blood coagulation disorders or when there is danger of fat embolism. Special warnings: The too rapid infusion of fat emulsions can cause fluid and/or fat overloading resulting in dilution of serum electrolyte concentrations. because of the possibility of pseudo-agglutination.5 * The amount of egg yolk phospholipids and α-tocopherol can vary is some countries. Especially where fat emulsions are administered for extended periods of time. Braun Melsungen AG 34209 Melsungen.8 6. Subject to sale by pharmacists only.Decreased blood potassium concentration (hypokalaemia) . sepsis.High concentration of acid substances in blood (acidosis) . Trade name in some countries: Medialipide®. Please refer to the country representative.0 g 100. medicines should not be used in pregnancy. Germany 1.Energy supply by means of glucose . Use in pregnancy and lactation The safety of Lipofundin® MCT/LCT during pregnancy and lactation has not been assessed. simultaneously with. the serum electrolyte concentrations – in particular serum potassium – and the acid-base balance. Lipofundin® MCT/LCT has been aproved for usage in this patient population in some countries. diseases of the reticuloendothelial system.0 g 25. congested states. or acute pancreatitis if accompanied by hyperlipaemia. B. blood coagulation. the patient's capacity to eliminate the infused fat from the circulation must be monitored.Carbohydrate component in parenteral nutrition . Soybean oil is a refined natural product containing neutral triglycerides of predominantly unsaturated fatty acids. especially when carbohydrates are not administered simultaneously. Paediatric patients: studies have shown the safety and effectiveness of Lipofundin® MCT/LCT as part of total parenteral nutrition in neonates and older children.0 g Glycerol 25. especially during the first trimester. liver function and platelet count should be closely monitored. osmolarity (mOsmo/L) 345 380 pH: 6. Water for injections Caloric Value (kcal): 1022 1908 Theor. Vasolipid® Specific Product Information may differ from country to country 31 . pulmonary oedema. The lipaemia must clear between daily infusions. impaired pulmonary diffusion capacity. 27 g L-methionine 1. manifest congestive cardiac failure. The use of fat emulsions as the sole source of calories may give rise to metabolic acidosis. In patients with suspected disorders of lipid metabolism.0 g Omega-3-acid triglycerides: 20.8 35.5 20.0 240 5190 (1240) 4020 (960) 2100 mmol 40.74 g 3.88 g 1.98 g (equivalent to Arginine 2.27 g 1.86 g Magnesium acetate · 4H2O – Sodium dihydrogen phosphate · 2H2O Potassium dihydrogen phosphate 0.48 g 4. refined: 80. warnings and precautions are observed.Product Description Parenteral Nutrition Lipoplus®/ Lipidem® 20% Composition 1000 ml of emulsion contains: Medium-chain triglycerides: 100.82 g 1. infants and children up to the 2nd year of life is not recommended.6 .6 5.0 31.96 g 2.98 g 2.37 g Calcium chloride · 2H2O 0. B.20 g 0. overhydration.0 g Eicosa-pentaenoic acid and docosahexaenoic acid: 8. water balance.21 g 2.6 5. Braun Melsungen AG 34209 Melsungen.51 g L-threonine 1.8. If the plasma triglyceride concentration still remains higher than 3 mmol/l. oxygen saturation) when the blood sample is taken before the lipids have been eliminated from the bloodstream.00 g 3.2 25.95 g 5. it is recommended to reduce the infusion rate.16 g 1.0 49. Braun Melsungen AG 34209 Melsungen.5 Indications: Source of calories and essential omega-6 fatty acids and omega-3 fatty acids as a component of a parenteral nutrition regimen for adults. lactate dehydrogenase.46 g 2. blood counts. The emulsion should always be brought to room temperature prior to infusion.54 g 8.50 g Water for injections to 1000 ml Nutriflex® Total amino acids (g/l) Total nitrogen (g/l) Total carbohydrates (g/l) Total energy kJ/l (kcal/l) Non-protein energy kJ/l (kcal/l) Osmolarity (mOsm/l) Electrolytes: + Na K+ Ca++ Mg++ Cl– H2PO4– Acetate peri (40/80) 40 5. and. blood glucose levels.00 g 1. hypothyroidism (in the presence of hypertriglyceridemia).17.0 22.00 g 150.7 80 2010 (480) 1340 (320) 900 mmol 27.76 g 3.00 g Sodium chloride 0.20 g 0.50 g 2. uncontrolled diabetes mellitus.50 g L-(+)-glutamic acid 1.0 2.0 basal (32/125) 1.7 50.70 g and to Glutamic acid) 2.47 g 1.56 g 1. There is as yet no clinical experience of the use of Lipoplus® in children.40 g 0.1 5.89 g 5.97 g 3. and besides have not been reported so far. if contraindications.9 special (70/240) 70 10.96 g 0.0 .57 g L-valine 2.56 g Sodium acetate · 3H2O Potassium hydroxide 0.45 g 0. This may be avoided by the concurrent infusion of carbohydrates.00 g 240.84 g (equivalent to L-lysine) 2.23 g 3.50 g 125.78 g 1.60 g 1.11 g 5.74 g 2.15 g 3.2 g Caloric content per liter: 7900 kJ ≈ 1910 kcal Osmolality: approx.82 g 1. Contraindications Nutriflex® is contraindicated in cases of hyperglycaemia.60 g Arginine glutamate 4.7 19.99 g 2.0 12. Subject to sale by pharmacists only. and liver function should be monitored.4): less than 0.23 g – 1. If the plasma triglyceride concentration rises to more than 3 mmol/l during administration of the fat emulsion.96 g L-phenylalanine 3. Particular caution should be exercised when co-infusing solutions that contain divalent electrolytes (such as calcium).40 g L-serine 3.56 g 2.68 g 3.40 g 137. water balance or body weight.72 g 2.58.25 g 264.7 4.0 3.53 g 1.24 g 2. vomiting.19 g 8.28 g 1.00 g Glucose · H2O (equivalent to anhydrous glucose) 80.0 plus (48/150) 48 6. especially when co-administering carrier solutions to which drugs have been added.52 g Sodium hydroxide 0.80 g 1.5 basal (32/125) 32 4.63 g 2. dosage recommendations.08 g 3.60 g 165.14 g 1000 ml Indication Parenteral nutrition.13 g L-lysine HCl 2.49 g 2. Adverse reactions Adverse reactions are not to be expected. – Unstable hemodynamic status with compromised vital functions (conditions of collapse and shock) – Fluid overload – Acute pulmonary edema Special warnings and precautions for use Before infusing a fat emulsion together with other solutions via a Y connector or bypass set.5 25. Possible intolerance reactions (nausea.73 g 3.98 g 3.41 g 2. blood glucose levels and acid-base balance are to be monitored. during long-term administration. enhanced plasma potassium levels.98 g 4.10 g 1000 ml plus (48/150) 2.25 g L-alanine 4. such as renal insufficiency. This should be borne in mind in patients with blood clotting disorders or suspected vitamin K deficiency.98 g 1. and there is only limited experience of its use in patients with diabetes mellitus or renal impairment.82 g L-tryptophan 0. Germany Specific Product Information may differ from country to country 32 . fish.15 g 2. Precautions Serum ionogram.8 150 3310 (790) 2510 (600) 1400 mmol 37.53 g 1. fat embolism – Known hypersensitivity to egg.0 15. It is therefore recommended to infuse an adequate quantity of intravenous carbohydrates or an amino acid solution containing carbohydrates along with the fat emulsion. Vitamin E can interfere with the effect of vitamin K in clotting factor synthesis.82 g 1.7 35.23 g 1000 ml special (70/240) 4.7 22.50 g 5.11. or soybean protein The following conditions are general contraindications to parenteral nutrition.22 g Amino acetic acid 1.0 g Essential fatty acid content per liter: Linoleic acid (omega-6): 48.42 g 6.12 g – 1.0 g Alpha-linolenic acid (omega-3): 5.5 mmol/l NaOH or HCl pH: 6.73 g 2. acidosis.00 g 4. B.85 g L-aspartic acid 1. untreated shock.0 .35 g 4. disorders of amino acid metabolism. coagulation status.34 g L-leucine 3.6 125 2640 (630) 2090 (500) 1140 mmol 49. Contraindications: Lipoplus® must not be used in any of the following conditions: – Severe hyperlipidemia – Serious blood clotting disorders – Acidosis – Intrahepatic cholestasis – Severe liver failure – Severe kidney failure – Acute phase of myocardial infarction or stroke – Acute thromboembolic disease.88 g 2.18 g 1.81 g 1.69 g L-histidine · HCl · H2O (equivalent to Histidine) 1. 410 mOsm/kg Titration acidity or alkalinity (to pH 7.00 g – 0.32 g 2. Electrolytes. In most patients this takes 5 to 6 hours beyond the end of the infusion.00 g 88.40 g 0. pancreatitis. Because of the specific composition of the nutrients the use of Nutriflex® in newborns. Germany Nutriflex® Composition Nutriflex® (mixed and ready for use 1000 ml) Active ingredients Nutriflex® peri (40/80) L-isoleucine 2.0 3. There is as yet only limited experience of the use of Lipoplus® for periods longer than seven days.08 g 3.00 g 1. Caution should be exercised in patients with conditions associated with impaired lipid metabolism. hepatic insufficiency. these must be permeable to fat emulsions. In hepatic or renal insufficiency the dosage is to be individually adjusted. acid-base balance. fasting lipemia should be ruled out before the start of the infusion.08 g – 2.5 4.9 30. and sepsis.5 .63 g 0.65 g L-proline 3. If filters are used.00 g – 0.62 g 1.12 g 5. Transient hypertriglyceridemia or elevated blood glucose levels may arise from the patient's metabolic status.18 g 0. the infusion should be stopped until the plasma triglyceride concentration normalizes. chills) and renal loss of glucose and amino acids with subsequent amino acid imbalances are due to a too rapid infusion rate. Subject to sale by pharmacists only.6 5.0 g Soybean oil. Hypertriglyceridemia 12 hours after the administration of fat is also indicative of abnormal lipid metabolism.5 14.98 g 3.82 g 3.72 g 4. the compatibility of these fluids should be checked. Serum triglycerides should be monitored during the infusion of Lipoplus®.35 g 1. Lipids may interfere with certain laboratory tests (such as bilirubin.17 g 0.03 g 1. 0 g 25. and acid-base balance should be monitored.065 g – 4.50 g 2.503 g 0. disorders of lipid metabolism such as pathological hyperlipaemia and conditions associated with triglyceride accumulation during parenteral nutrition.40 g 4.12 g 3.0 g 25.175 g 3.3 0.98 g 2.70 g 3. intrahepatic cholestasis.137 g 0. The infusion should be stopped in these cases.00 g 1. e. strict aseptic precautions should be taken.7 g Total glucose 80 g Total lipids 50 g Total energy 4000/955 (KJ/Kcal) Non-Protein 3330/795 energy (KJ/Kcal) Osmolality 920 (mOsm/kg) Osmolarity (theoret. flushing. should be corrected before administration. liver function.625 g 2.19 g Alanine 4. Blood glucose levels should be monitored and the rate of infusion adjusted or insulin should be administered if hyperglycaemia occurs.85 g 5.0 g 165.49 g 8. Braun Melsungen AG 34209 Melsungen.441 g ride dihydrate Zinc acetate 6. allergic reactions.82 g 2.0 g 25.0 g 180. insufficient or contraindicated.60 g 3.08 g 4.725 g Histidine 1. Likewise.943 g acetate Magnesium 0. untreated or complicated diabetes mellitus. Nausea or vomiting may occasionally occur.21 g 6. administration of NuTRIflex® Lipid formulations may lead to hyperglycaemia.10 g Leucine 3.0 g 150.49 g Aspartic acid 1. hyperthermia. hypertriglyceridaemia 12 hours after fat infusion indicates disorders of fat metabolism.0 Magnesium 3.41 g – 4. Too rapid infusion can cause fluid overloading resulting in overhydration.25 g Glucose mono88.82 g 4.96 g – hydrochloride monohydrate Histidine 1. blood coagulation.145 g 6.725 g 4.04 60 20 60 – – – – – – – 71. sweating.80 g 1.0 g hydrate Anhydrous 80. and platelet count should be regularly monitored.84 g 3.505 g Arginine 2. Precautions Should be administered with caution to patients with cardiac or renal dysfunction.50 g 1. Undesirable effects Undesirable effects related to the components of NuTRIflex® Lipid peri.135 g 6.505 g 4.19 g 2.8 g 150 g 50 g 5300/1265 4500/1075 1540 1215 mmol 50 35 4.644 g acetate tetrahydrate Calcium chlo0.24 g 3.145 g Threonine 1.3 5.Parenteral Nutrition Product Description Parenteral Nutrition NuTRIflex® Lipid Composition NuTRIflex® Lipid (mixed and ready for use 1250 ml) Active ingredients NuTRIflex® Lipid NuTRIflex® Lipid NuTRIflex® Lipid NuTRIflex® Lipid NuTRIflex® Lipid peri plus plus without special special without electrolytes electrolytes Isoleucine 2. chest and back pain.170 g 2.24 g 4. During infusion in very rare cases the amino acids might cause hyperazotaemia and acidosis. irreversible liver damage. especially in the presence of coma related to keto-acidosis or diabetic precoma.03 Chloride 48 Phosphate 7. hyperkalaemia.0 g glucose Soya bean oil 25. vomiting.08 g 5. NuTRIflex® Lipid special and NuTRIflex® Lipid special without electrolytes are rare. Give with caution in conditions of impaired lipid metabolism as in renal insufficiency. NuTRIflex® Lipid plus.0 g 198.26 g 2.82 g 8. diabetes mellitus.0 0.25 g 5. impaired liver function. Fluid.25 g 1. The infusion can be resumed after the disappearance of the symptoms and/or the elevated serum triglyceride levels with reduced dose and/or reduced infusion rate. sepsis and in conditions of altered amino acid metabolism.0 g 25. cyanosis.03 g – 2. The patient’s capacity to eliminate the infused fat from the circulation should be monitored.21 g 4. In the event of a forced infusion an osmotic diuresis might occur as a result of the high osmolality. sleepiness.135 g Glycine 1. Contraindications Acute shock.34 g – 3.473 g 0.0 g 180. Care should be taken to avoid complications of catheterisation including air embolism and venous thrombosis.03 45 15 45 – – – – – – – 48 g 6.0 g Medium chain 25.18 g 2.544 g tate trihydrate Potassium 2.175 g Tryptophan 0.82 g 2.60 g 3. hypercoagulability of the blood. NuTRIflex® Lipid NuTRIflex® Lipid NuTRIflex® Lipid NuTRIflex® Lipid NuTRIflex® Lipid peri plus plus without special special without electrolytes electrolytes 1.96 g 2. B.47 g Lysine – – 2.120 g – 0.50 g 1.98 g Lysine hydro2.588 g 6.) 840 (mOsm/l) Electrolytes: mmol Sodium 50 Potassium 30 Calcium 3.95 g Serine 3. acidosis.976 g 0. As with other solutions containing glucose. overhydration.8 g 10 g 180 g 50 g 6175/1475 5005/1195 2090 1545 mmol 67 47 5.081 g Sodium ace0.0 g 198.98 g – Methionine 1.0 g 165. Germany Specific Product Information may differ from country to country 33 .35 g 2.35 g 3.34 g 2.73 g – 3.858 g 0.6 mg di-hydrate Total amino acids 40 g Total nitrogen 5.464 g 0.0 g 25.00 g 3. hyperlipaemia.105 g 4.42 g 3. Subject to medical prescription. impaired pulmonary diffusion capacity.89 g 2. chills.12 g 4. congested states.73 g – 3.48 g 5. headache.611 g 1. electrolyte. These infusions should not be given to neonates and infants up to the age of 24 months.69 g 2.18 g 3.51 g 4.57 g 0.0 g 25. the patient’s haemogram. and acid-base balance.98 g 1.21 g 6.89 g ( aminoacetic acid) Proline 3.975 g – chloride Lysine 2.800 g hydroxide Sodium chloride 1.313 g 4.277 g 3.5 Acetate 40 In patients suspected to have disorders of fat metabolism. Close monitoring of the patient’s general condition and his/her plasma triglyceride levels is recommended. severe disorders of blood coagulation.. nausea. hypothyroidism (if hypertriglyceridaemic). Immediate (acute) reactions related to the lipid are dyspnoea. pulmonary oedema. pancreatitis.58 mg 48 g 6.0 g 25.0 Zinc 0. inborn errors of amino acid metabolism.82 g 5.80 g 2.68 g 1.0 4.76 g 5.625 g Glutamic acid 3. In the case of fasting hypertriglyceridaemia the administration of fat is contraindicated.65 g 1.76 g 3.00 g Valine 2.50 g 4. Especially where the product is administered for extended periods of time.8 g 150 g 50 g 5300/1265 4500/1075 1350 1055 – – – – – – – – – 1. severe uraemia when dialysis facilities are not available.0 g triglycerides Indications When oral or enteral feeding is not possible.48 g Lysinehydrate – – 3.434 g 0. electrolyte.0 g 25. Disorders of the fluid. acute thrombo-embolism or fat embolism.0 g 150.68 g 0.13 g 3.78 mg 71.8 g 10 g 180 g 50 g 6175/1475 5005/1195 1840 1330 – – – – – – – – – Sodium dihydrogen phosphate dihydrateSodium 0. NuTRIflex® Lipid plus without electrolytes.21 g 4.60 g 5.779 g 8.42 g Phenylalanine 3. fasting lipaemia should be excluded.95 g 5. Those that do occur are usually reversible and subside when therapy is discontinued. acute phase of myocardial and cerebral infarction. As with all parenteral solutions administered through a peripheral/central venous catheter.g. 0242 mg Sodium molybdate · 2 H2O (equivalent to 0. B. Notes: Care is to be taken in cases of impaired liver or kidney function which requires a check of the serum concentrations and. Special warnings and special precautions for use In case of biliary tract disease administration of Tracutil® may lead to an accumulation of copper and manganese.0 µmol of iron) Zinc chloride.e.053 mg Chromium (III) chloride · 6 H2O (equivalent to 0.815 mg (equivalent to 50. Germany Composition 1 ampoule of 10 ml contains Active ingredients: 6.0 µmol of iodide) Excipients: Hydrochloric acid. infants and children.046 mg Copper (II) chloride · 2 H2O (equivalent to 12.0 µmol of zinc) 1. which improves again after chromium supplementation. Caution is also necessary in case of Wilson’s disease and disturbed iron storage (i. haemosiderosis or haemochromatosis) because copper and iron supplementation may cause an additional accumulation of these elements in such cases. Undesirable effects Individual cases of anaphylactic reactions to parenterally administered iron have been reported. reduction of the dose. Contra-indications Increased serum levels of the trace elements contained in Tracutil®.979 mg Manganese (II) chloride · 4 H2O (equivalent to 10. water for injections. For this reason. Use in pregnancy and lactation: There is no data available on administration during pregnancy or in the lactation period. Therapeutic indications Provision of basic trace element requirements during long-term parenteral nutrition in adult patients. Braun Melsungen AG 34209 Melsungen.0 µmol of manganese) 2.0789 mg Sodium selenite · 5 H2O (equivalent to 0.Product Description Parenteral Nutrition Tracutil® 0.1 µmol of molybdenum) 34 .0 µmol of fluoride) Potassium iodide) 0. Dispensing classification Subject to medical prescription.958 mg Iron (II) chlorid · 4 H2O (equivalent to 35.260 mg (equivalent to 30. The benefits must therefore be carefully weighed against the risks. Tracutil® should not be administered to newborn infants. where appropriate.0 µmol of copper) 0.166 mg (equivalent to 1. patients suffering from insulin-dependent diabetes mellitus and chromium deficiency may require a reduction in the amount of insulin they receive during administration of Tracutil®. anhydrous 6. Chromium deficiency leads to a decrease in glucose tolerance.3 µmol of selenium) Sodium fluoride 1.2 µmol of chromium) 0. 8 µg 2. of which n saturated fatty acids of which MCT saturated fatty acids of which MCT saturated fatty acids of which MCT n n n essential fatty acids -3 fatty acids n n essential fatty acids -3 fatty acids n n essential fatty acids -3 fatty acids n Fibre Water Sodium Potassium Calcium Magnesium Phosphorus Chloride Iron Zinc Copper Iodine Chromium Fluoride Manganese Molybdenum Selenium Vitamin A (RE) Vitamin D Vitamin E (-TE) Vitamin K Vitamin B1 Vitamin B2 Vitamin B6 Vitamin B12 Vitamin C Niacin (NE) Folic acid Pantothenic acid Biotin Choline Natural mixture of carotenoids Beta-Carotene Fibre Water Sodium Potassium Calcium Magnesium Phosphorus Chloride Iron Zinc Copper Iodine Chromium Fluoride Manganese Molybdenum Selenium Vitamin A (RE) Vitamin D Vitamin E (-TE) Vitamin K Vitamin B1 Vitamin B2 Vitamin B6 Vitamin B12 Vitamin C Niacin (NE) Folic acid Pantothenic acid Biotin Choline Natural mixture of carotenoids Beta-Carotene Fibre Water Sodium Potassium Calcium Magnesium Phosphorus Chloride Iron Zinc Copper Iodine Chromium Fluoride Manganese Molybdenum Selenium Vitamin A (RE) Vitamin D Vitamin E (-TE) Vitamin K Vitamin B1 Vitamin B2 Vitamin B6 Vitamin B12 Vitamin C Niacin (NE) Folic acid Pantothenic acid Biotin Choline Natural mixture of carotenoids Beta-Carotene Fibre Water Sodium Potassium Calcium Magnesium Phosphorus Chloride Iron Zinc Copper Iodine Chromium Fluoride Manganese Molybdenum Selenium Vitamin A (RE) Vitamin D Vitamin E (-TE) Vitamin K Vitamin B1 Vitamin B2 Vitamin B6 Vitamin B12 Vitamin C Niacin (NE) Folic acid Pantothenic acid Biotin Choline Beta-Carotene 35 .5 µg 52.15 g 5.0 g 200 ml 1260 kJ 12 g Nutricomp® Standard Nutrition information per Energy Protein (milk and soy) 100 ml 421 kJ 100 kcal 3.44 mg 0.3 g 0g 420 ml 0.5 mg 150 mg 1.1 g 25 g 15 g 13 g 3g 2g 0g 380 ml 0.75 g 1125 mg 562.5 mg 7 µg 0.5 mg 750 mg 9 mg 11.3 mg 0.1 g 150 mg 75 mg 20 mg 65 mg 100 mg 1.5 µg 50 mg 9 mg 150 µg 3 mg 25 µg 150 mg – 0.99 g 0.3 µg 10 mg 1.5 µg 0.2 mg 150 µg 13 µg 7 µg 0.1 mg 68.75 mg 20 g 5.25 µg 150 mg 13.75 mg 1.5 mg 37.8 g 1.005 g 3.3 mg 0.2 mg 0.6 mg 5 µg 30 mg – 0.5 mg 30 mg 97.9 g 3.5 mg 150 mg 487.75 g 10 g 2.3 mg 2.0 µg 30 mg – 40 g 11 g 7.8 g 2.025 g 16.5 µg 10.5 g 750 mg 375 mg 100 mg 325 mg 500 mg 6 mg 6 mg 750 µg 65 µg 35 µg 0.7 g 6. of which n Fat.7 mg 1.30 mg 0.2 g 340 mg 144 mg 54 mg 120 mg 230 mg 3.6 g ≤0.8 mg 30 µg 0.8 g ≤0.1 mg 0.8 mg 2.1 g 1.5 g 0.3 mg 15 µg 13.04 g 16.2 mg 1.1 mg 0.2 g 0.5 g 1.5 mg 10.6 mg 5 µg 30 mg – 0.6 g 2.5 g 8.7 g 5g 2.6 g 0.5 µg 50 mg 9 mg 150 µg 3 mg 25 µg 150 mg – 0.5 µg 225 mg – 0.1 µg 37 mg 4.1 mg 68.5 g 750 mg 375 mg 100 mg 325 mg 500 mg 6 mg 6 mg 750 µg 65 µg 35 µg 0.2 mg 0.15 g 225 mg 112.8 g Nutricomp® Standard Fibre Nutrition information per Energy Protein (milk and soy) 100 ml 437 kJ 104 kcal 3.5 µg 135 µg 1.55 µg 18 mg 2.5 mg 2.2 mg 0.5 g 83 ml 0.5 mg 52.22 mg 0.72 g – 151 ml 0. of which n n 18.5 µg 675 µg 7.8 g 0.25 mg 225 µg 19.0 mg 12 µg 0.02 g 5g 3g 2.2 mg 170 µg 25 µg 16 µg 0. of which n 13.8 g Nutricomp® Energy Nutrition information per Energy Protein (casein) 100 ml 632 kJ 150 kcal 7.8 g 7.6 g 0.5 g 1.2 g 0.36 mg 0.4 mg 73 µg 1.9 mg 7.5 g 500 ml 3160 kJ 750 kcal 38 g 150 kcal 300 kcal Carbohydrates.5 mg 225 µg 4.2 mg 10 µg 7 µg 90 µg 1 µg 1.5 g 7.44 mg 1.2 g 0.5 mg 7 µg 0.2 mg 10 µg 7 µg 90 µg 1 µg 1.92 g 0.3 g 0.58 mg 12 µg 8.0 g 1.5 µg 0.5 mg 1 mg 50 µg 35 µg 450 µg 5 µg 7.5 mg Carbohydrates.15 mg 94 g 9.5 µg 1.5 mg Carbohydrates.2 mg 1.3 µg 147 µg 1.2 mg 0.5 mg 1.0 mg 24 µg 0.5 g 0.3 g 1.5 µg 22.4 g 1.4 g 0g 76 ml 0.26 g 0g 84 ml 0.1 mg 8. of which n Fat.22 mg 0.2 mg 0.2 g 1.3 g 0.8 g 1. of which n Fat.1 g 75 ml 0.7 µg 4.75 g 2.7 g 0.3 mg 0.Enteral Nutrition Product Description Enteral Nutrition Nutricomp® Drink Plus Nutrition information per Energy Protein (milk and soy) 100 ml 630 kJ 6.2 mg 150 µg 13 µg 7 µg 0.1 g 170 mg 72 mg 27 mg 60 mg 115 mg 1.8 mg 30 µg 0.44 g 0.3 g 0.2 mg 23 µg 17 µg 294 µg 3.2 mg 0.8 g 500 ml 2105 kJ 500 kcal 18.3 µg 10 mg 1.45 µg 30 mg 2.25 mg 1125 µg 97.4 mg 340 µg 50 µg 32 µg 0.9 g 0.6 g 0.5 µg 45 mg – 0.1 g 150 mg 75 mg 20 mg 65 mg 100 mg 1.5 mg 1 mg 50 µg 35 µg 450 µg 5 µg 7.5 mg 35 µg 1 mg 1 mg 1 mg 1. of which Carbohydrates.7 g 4.008 g 3.5 mg 35 µg 1 mg 1 mg 1 mg 1. of which n n 13.53 g 1.3 g 3.5 µg 0.5 µg 4.15 mg 0.8 mg 147 µg 2.36 g <0.7 mg 45 µg 0.5 g 415 ml 0.5 mg 1.2 g 0.8 g 500 ml 2185 kJ 520 kcal 18.6 mg 1.18 mg 0.2 mg 16 µg 60 mg – n n sugar Lactose sugar Lactose sugar Lactose sugar of which Lactose saturated fatty acids of which MCT monounsaturated fatty acids polyunsaturated fatty acids of which -3 fatty acids n Fat.5 mg 75 µg 67.5 g 1. 5 g 0.8 mg 7.3 mg 0.25 µg 150 mg 13.8 370 ml 0.1 g 2.5 mg 2.8 mg 46 µg 1.4 g 0.13 mg 0.02 g 5g 3g 2.2 g 0.56 mg 1.5 µg 22.3 mg 1.8 g 1.26 mg 0.95 mg 9.6 g 74 ml 0.007 g 12.26 mg 0.26 mg 13 µg 9.1 mg 64.7 mg 1.75 mg 1.5 g 3. of which n n n 12. of which n n Fat.5 mg Carbohydrates.26 mg 0.5 mg 150 mg 1.5 mg 37.2 g 2.5 g 1.5 g 0.5 g 17.25 mg 1125 µg 97.8 g 8.2 mg 0.5 µg 0.8 mg 975 µg 85 µg 46 µg 0.24 mg 0.3 mg 65 µg 46 µg 585 µg 6.5 µg 225 mg – 0.5 g 750 mg 375 mg 100 mg 325 mg 500 mg 6 mg 6 mg 750 µg 65 µg 60 µg 0.39 µg 13 mg 2.1 g 25 g 15 g 13 g 3g 2g 10 g 375 ml 0.78 mg 6.6 g 500 ml 2750 kJ 650 kcal 28 g Nutricomp® Hepa Nutrition information per Energy Protein (milk) of which n 100 ml 550 kJ 130 kcal 4g 1.65 mg Water Sodium Potassium Calcium Magnesium Phosphorus Chloride Iron Zinc Copper Iodine Chromium Fluoride Manganese Molybdenum Selenium Vitamin A (RE) Vitamin D Vitamin E (-TE) Vitamin K Vitamin B1 Vitamin B2 Vitamin B6 Vitamin B12 Vitamin C Niacin (NE) Folic acid Pantothenic acid Biotin Choline Natural mixture of carotenoids Beta-Carotene 36 .26 mg 13 µg 9.Product Description Enteral Nutrition Nutricomp® Energy Fibre Nutrition information per Energy Protein (milk and soy) 100 ml 655 kJ 156 kcal 7.5 g Nutricomp® MCT Nutrition information per Energy Protein (milk and soy) 100 ml 550 kJ 130 kcal 5.6 g 0.035 g 61.5 µg 0.5 g 14.1 µg 0.2 g 11 g 2.3 mg 2 µg 65 mg 12 mg 195 µg 3.9 g 0.6 g 1g <0.26 mg 0.1 µg 117 µg 1.09 g 156 mg 71.1 g 500 ml 2160 kJ 515 kcal 20.46 g 780 mg 358 mg 130 mg 299 mg 455 mg 7.5 g 500 ml 3275 kJ 780 kcal 38 g Protein (milk and soy) Nutricomp® Standard Fibre D Nutrition information per Energy 100 ml 432 kJ 103 kcal 4.5 mg 1 mg 50 µg 45 µg 450 µg 5 µg 15 mg 35 µg 1 mg 1 mg 1 mg 1. of which n n sugar Lactose sugar Lactose starch saturated fatty acids monounsaturated fatty acids essential fatty acids -3 fatty acids sugar Lactose sugar Lactose Fat.34 mg 39 µg 0.5 µg 45 mg – 0.75 g 1125 mg 562.5 µg 135 µg 1.5 g 0.5 µg 1.3 µg 20 mg 1.56 mg 195 µg 17 µg 9.4 g 3g 2.26 mg 0.26 mg 0.4 g 2g 75 ml 0.5 µg 100 mg 9 mg 150 µg 3 mg 25 µg 150 mg 1.2 mg 1. of which n saturated fatty acids of which MCT saturated fatty acids of which MCT saturated fatty acids of which MCT n n essential fatty acids -3 fatty acids n n n essential fatty acids n essential fatty acids Fibre Water Sodium Potassium Calcium Magnesium Phosphorus Chloride Iron Zinc Copper Iodine Chromium Fluoride Manganese Molybdenum Selenium Vitamin A (RE) Vitamin D Vitamin E (-TE) Vitamin K Vitamin B1 Vitamin B2 Vitamin B6 Vitamin B12 Vitamin C Niacin (NE) Folic acid Pantothenic acid Biotin Choline Natural mixture of carotenoids Beta-Carotene Fibre Water Sodium Potassium Calcium Magnesium Phosphorus Chloride Iron Zinc Copper Iodine Chromium Fluoride Manganese Molybdenum Selenium Vitamin A (RE) Vitamin D Vitamin E (-TE) Vitamin K Vitamin B1 Vitamin B2 Vitamin B6 Vitamin B12 Vitamin C Niacin (NE) Folic acid Pantothenic acid Biotin Choline Natural mixture of carotenoids Beta-Carotene Fibre Water Sodium Potassium Calcium Magnesium Phosphorus Chloride Iron Zinc Copper Iodine Chromium Fluoride Manganese Molybdenum Selenium Vitamin A (RE) Vitamin D Vitamin E (-TE) Vitamin K Vitamin B1 Vitamin B2 Vitamin B6 Vitamin B12 Vitamin C Niacin (NE) Folic acid Pantothenic acid Biotin Choline Natural mixture of carotenoids Beta-Carotene Fibre 395 ml 0. of which n Fat.13 g 195 mg 97.008 g 4.1 µg 0.15 mg 94 g 8.3 mg 1.4 ml 0.1 µg 0.56 mg 1.3 mg 1.2 mg 0.7 mg 45 µg 0.5 mg 52.15 mg 0.5 µg 10.39 µg 13 mg 2.45 µg 30 mg 2.5 µg 39 mg – 0.3 mg 2 µg 65 mg 12 mg 195 µg 3.5 µg 675 µg 7.13 mg 0.3 mg 39 µg 0.05 g 5.13 mg 500 ml 2750 kJ 650 kcal 20 g 9g 77.6 g 0.9 mg 7.8 mg 46 µg 1.8 mg 7.5 µg 9.25 mg 225 µg 19.65 mg branched chain amino acids Carbohydrates. of which n Fat.65 g 975 mg 488 mg 130 mg 423 mg 650 mg 7.3 µg 1.3 mg 0.5 µg 52.5 mg 1.8 mg 30 µg 0.5 g 8g 0.5 mg 10.13 mg 86 g 8.6 g 0. of which n n 18.1 g 79 ml 0.5 mg 1.5 µg 4.8 mg 2.2 mg 10 µg 9 µg 90 µg 1 µg 3 mg 7 µg 0.5 µg 9.15 g 225 mg 112.7 g 0.3 mg 0.56 mg 195 µg 16.5 mg 26 mg 84.3 g 3.5 mg 30 mg 97.6 g 0.5 g 0.8 mg 975 µg 85 µg 46 µg 0.5 mg 750 mg 9 mg 11.5 µg 0.1 g 10 g 417 ml 0.2 mg 0.5 mg 150 mg 487.75 mg Carbohydrates.5 g 1.5 g 2.5 mg 26 mg 60 mg 91 mg 1.5 g 3g 1.65 mg 1.9 mg 33 µg 195 mg – 0.5 mg 225 µg 4.5 mg 130 mg 1.3 mg 15 µg 13.1 µg 117 µg 1.2 mg 150 µg 13 µg 12 µg 0.2 g 0.3 mg 1.6 mg 5 µg 30 mg 0.1 µg 0.0 g 83. of which n n 17 g 1.2 mg 0.5 mg 75 µg 67.25 g 29 g 17.1 g 150 mg 75 mg 20 mg 65 mg 100 mg 1.3 mg 65 µg 46 µg 585 µg 6.78 mg 6.8 g 3.5 µg 39 mg – 0.04 g 22 g 15 g 13 g 5g Carbohydrates.6 g 0.3 µg 2 mg 9.6 g 2.8 g 15.9 mg 33 µg 195 mg – 0.9 µg 9.1 mg 0. 37 g 19 g 94 g 4.6 g 0.3 mg 65 µg 46 µg 585 µg 6.9 g 3.1 g 79 ml 0.7 g 0.6 mg 2 mg 200 µg 17.38 mg 0.1 g 6.9 g 1.4 mg 39.8 397 ml 0.8 mg 6.8 mg 50 µg 29 µg 250 µg 2.27 mg 0.5 g 3g 1.39 µg 13 mg 2.56 mg 1.3 mg 39 µg 0.5 g 2.7 µg 40 mg 0.26 mg 0.27 mg 13.3 mg 1.3 g 78 ml 0.09 mg 0. of which n n n saturated fatty acids of which MCT Fat.5 mg 26 mg 84.8 mg 26.8 g 0.3 µg 0.4 g 10 g 91.1 g 0.7 g 1.38 mg 0.3 µg 0.1 mg 0.9 g 0.6 mg 2.75 mg 100 µg 13 µg 5 µg 0.3 µg 2 mg 9.35 g 1.Enteral Nutrition Product Description Enteral Nutrition Nutricomp® Intensiv Nutrition information per Energy Protein (milk and soy) 100 ml 550 kJ 130 kcal 6.5 mg 1 mg 20 µg 0.8 mg 975 µg 85 µg 46 µg 0.7 µg 20 mg 47 µg 1.65 g 975 mg 488 mg 130 mg 423 mg 650 mg 7.3 µg 9.14 g 120 mg 50 mg 18 mg 40 mg 96 mg 0.15 mg 10 µg 5.43 mg 0.8 mg 500 µg 65 µg 25 µg 0.9 µg 0.5 mg 3.5 g 1.5 µg 9. gelatine) Carbohydrates.67 g 998 mg 499 mg 133 mg 432 mg 665 mg 8 mg 10 mg 998 µg 86 µg 47 µg 0.8 g 3.7 g 9.5 µg 3 mg 23 µg 0.56 mg 195 µg 17 µg 9.3 g 0.7 mg milk.07 g 18.7 g 0.8 mg 46 µg 1.5 mg 130 mg 1.014 g 3. of which n 3. of which n Fat.0 g 18.3 µg 12 µg 120 µg 1.67 g 2.2 g 1.3 mg 1.8 g 1.27 mg 0.6 mg 86.3 mg 1.045 g 29 g 18 g 15 g 8.4 µg 26.5 g 9.5 µg 0.9 mg 33 µg 195 mg – 0.5 g n of which glutamine sugar Lactose saturated fatty acids of which MCT sugar Lactose Carbohydrates.8 mg 7.2 g 0.3 µg 4.5 mg 133 mg 1.65 mg n Fibre Water Sodium Potassium Calcium Magnesium Phosphorus Chloride Iron Zinc Copper Iodine Chromium Fluoride Manganese Molybdenum Selenium Vitamin A (RE) Vitamin D Vitamin E (-TE) Vitamin K Vitamin B1 Vitamin B2 Vitamin B6 Vitamin B12 Vitamin C Niacin (NE) Folic acid Pantothenic acid Biotin Choline Beta-Carotene Fibre Water Sodium Potassium Calcium Magnesium Phosphorus Chloride Iron Zinc Copper Iodine Chromium Fluoride Manganese Molybdenum Selenium Vitamin A (RE) Vitamin D Vitamin E (-TE) Vitamin K Vitamin B1 Vitamin B2 Vitamin B6 Vitamin B12 Vitamin C Niacin (NE) Folic acid Pantothenic acid Biotin Choline Beta-Carotene <0.1 g 84 ml 0.9 g 13 g 1.9 mg 0.9 g 1. of which n n essential fatty acids n essential fatty acids -3 fatty acids n essential fatty acids Fibre Water Sodium Potassium Calcium Magnesium Phosphorus Chloride Iron Zinc Copper Iodine Chromium Fluoride Manganese Molybdenum Selenium Vitamin A (RE) Vitamin D Vitamin E (-TE) Vitamin K Vitamin B1 Vitamin B2 Vitamin B6 Vitamin B12 Vitamin C Niacin (NE) Folic acid Pantothenic acid Biotin Choline Natural mixture of carotenoids Beta-Carotene 2.08 mg 0.8 g 18.5 µg 0.6 g 3.08 mg 0.57 g 0.3 g 1.7 g 390 ml 0.26 mg 13 µg 9.13 mg 33.75 g 5.13 mg 0.3 mg 2 µg 133 mg 12 mg 200 µg 4 mg 33 µg 200 mg 0. of which n n Nutricomp® Immun Nutrition information per Energy 100 ml 572 kJ 500 ml 2860 kJ Nutricomp® Peptid Nutrition information per Energy Protein (hydrolysate from 100 ml 424 kJ 500 ml 2120 kJ 136 kcal 680 kcal 100 kcal 500 kcal 6.6 mg 25 µg 100 mg – 37 .8 g 0.1 µg 117 µg 1.8 g 0.7 g 600 mg 250 mg 90 mg 200 mg 480 mg 4.65 mg 1.7 g <0.27 mg 0. of which n sugar Lactose saturated fatty acids of which MCT Fat.67 mg 1. soy.3 µg 4 mg 9.13 mg 65 g 6.13 g 195 mg 97.26 mg 0.78 mg 6.51 mg 5 µg 20 mg – – 420 ml 0.3 mg 2 µg 65 mg 12 mg 195 µg 3.5 mg 1.26 mg 0.2 g 7.13 mg 0.13 g 200 mg 99.33 mg 67 µg 60 µg 599 µg 6.6 mg 4.009 g 5.7 µg 50 µg 0.3 mg 1.1 µg 0.1 µg 0.5 µg 23 mg 5 mg 100 µg 2.5 µg 39 mg – 0.5 g 500 ml 2750 kJ 650 kcal 33 g Protein (wheat protein hydrolysate and milk protein) Carbohydrates. Notes 38 . Enteral Nutrition Notes 39 . 00/0 Nr. Braun Melsungen AG | Hospital Care | 34209 Melsungen | Germany Tel. 00.nutrition-partner.00.com | www. 606 4181 .com B.bbraun.B. +49 5661 71-0 | www.